Elesclomolum

Elesclomolum Uses, Dosage, Side Effects, Food Interaction and all others data.

Elesclomolum is a novel, injectable, drug candidate that kills cancer cells by elevating oxidative stress levels beyond a breaking point, triggering programmed cell death. In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy of certain chemotherapy agents, with minimal additional toxicity, at moderate doses. It is being developed by Synta Pharmaceuticals.

Elesclomolum is a first-in-class heat shock protein 70 (Hsp70) inducer that activates natural killer (NK) cell-mediated tumor killing.

Trade Name Elesclomolum
Generic Elesclomol
Elesclomol Other Names Elesclomol, Élesclomol, Elesclomolum
Type
Formula C19H20N4O2S2
Weight Average: 400.518
Monoisotopic: 400.102767284
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Elesclomolum
Elesclomolum

Uses

Investigated for use/treatment in melanoma.

How Elesclomolum works

Elesclomolum acts through a novel mechanism of action. Elesclomolum has been shown to rapidly cause a dramatic increase in oxidative stress (ROS) inside cancer cells. The prolonged elevation of ROS inside cancer cells induced by elesclomol causes the cell to exceed a critical breaking point and undergo apoptosis. The triggering of the mitochondrial apoptosis pathway is observed within the first six hours of applying elesclomol. Cancer cells operate at a much higher intrinsic level of ROS than normal cells, and have a greatly reduced anti-oxidant capacity compared to normal cells. This leaves them more vulnerable to an agent such as elesclomol that elevates oxidative stress. In similar experiments at similar doses, elesclomol has been found to have little to no impact on normal cells.

Innovators Monograph

You find simplified version here Elesclomolum

*** Taking medicines without doctor's advice can cause long-term problems.
Share